Budget Amount *help |
¥131,430,000 (Direct Cost: ¥101,100,000、Indirect Cost: ¥30,330,000)
Fiscal Year 2022: ¥28,860,000 (Direct Cost: ¥22,200,000、Indirect Cost: ¥6,660,000)
Fiscal Year 2021: ¥28,860,000 (Direct Cost: ¥22,200,000、Indirect Cost: ¥6,660,000)
Fiscal Year 2020: ¥28,860,000 (Direct Cost: ¥22,200,000、Indirect Cost: ¥6,660,000)
Fiscal Year 2019: ¥28,860,000 (Direct Cost: ¥22,200,000、Indirect Cost: ¥6,660,000)
Fiscal Year 2018: ¥15,990,000 (Direct Cost: ¥12,300,000、Indirect Cost: ¥3,690,000)
|
Outline of Final Research Achievements |
In this planned research, we have developed several advanced proteomics methods to analyze the ubiquitin system and strongly promoted this research project area. Major achievements include the elucidation of the ubiquitin decoders for proteasomal degradation, the discovery of the liquid-liquid phase separation of the proteasome, the development of monobodies that inhibit the ubiquitin decoder, and the discovery of new architectures of branched ubiquitin chains induced by PROTAC and its formation mechanisms. We believe that these findings will contribute to the future development of ubiquitin research and drug discovery.
|